We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$5.56B
AUM Growth
–
Cap. Flow
+$5.59B
Cap. Flow %
100.58%
Top 10 Hldgs %
34.75%
Holding
318
New
318
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$284M
2
ETN icon
Eaton
ETN
+$281M
3
C icon
Citigroup
C
+$238M
4
PCG icon
PG&E
PCG
+$193M
5
TAP icon
Molson Coors Class B
TAP
+$173M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 16.37%
2 Healthcare 16.25%
3 Technology 12.88%
4 Consumer Staples 11.82%
5 Industrials 11.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETN icon
1
Eaton
ETN
$142B
$293M 5.28%
+4,456,178
New +$281M
PFE icon
2
Pfizer
PFE
$143B
$273M 4.91%
+10,274,072
New +$284M
C icon
3
Citigroup
C
$215B
$238M 4.28%
+4,957,577
New +$238M
PCG icon
4
PG&E
PCG
$39B
$191M 3.45%
+4,186,905
New +$193M
MDT icon
5
Medtronic
MDT
$112B
$170M 3.06%
+3,298,045
New +$163M
TAP icon
6
Molson Coors Class B
TAP
$7.97B
$163M 2.94%
+3,415,755
New +$173M
QCOM icon
7
Qualcomm
QCOM
$171B
$154M 2.77%
+2,521,297
New +$161M
AAPL icon
8
Apple
AAPL
$5.05T
$153M 2.76%
+10,822,476
New +$166M
CIT
9
DELISTED
CIT Group Inc.
CIT
$148M 2.67%
+3,177,398
New +$140M
DD
10
DELISTED
Du Pont De Nemours E I
DD
$146M 2.63%
+2,935,975
New +$148M
MRK icon
11
Merck
MRK
$323B
$132M 2.38%
+2,979,555
New +$133M
OXY icon
12
Occidental Petroleum
OXY
$55.6B
$130M 2.35%
+1,524,343
New +$129M
TGT icon
13
Target
TGT
$66.5B
$123M 2.22%
+1,791,923
New +$125M
WFC icon
14
Wells Fargo
WFC
$257B
$121M 2.17%
+2,920,494
New +$114M
MET icon
15
MetLife
MET
$62.4B
$111M 1.99%
+2,709,996
New +$99.7M
JPM icon
16
JPMorgan Chase
JPM
$926B
$109M 1.96%
+2,061,657
New +$105M
RDS.A
17
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$99.3M 1.79%
+1,557,152
New +$103M
VZ icon
18
Verizon
VZ
$201B
$93M 1.67%
+1,846,622
New +$94.2M
EMC
19
DELISTED
EMC CORPORATION
EMC
$91.7M 1.65%
+3,881,126
New +$91.5M
SFD
20
DELISTED
SMITHFIELD FOODS,INC
SFD
$88.6M 1.59%
+2,705,571
New +$76.6M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.78B
$82.7M 1.49%
+736,879
New +$86.4M
ORCL icon
22
Oracle
ORCL
$346B
$81.7M 1.47%
+2,661,434
New +$88.3M
PF
23
DELISTED
Pinnacle Foods, Inc.
PF
$75.2M 1.35%
+3,114,537
New +$75.8M
CAG icon
24
Conagra Brands
CAG
$7.4B
$72.2M 1.3%
+2,657,624
New +$71.9M
MSFT icon
25
Microsoft
MSFT
$2.96T
$69.9M 1.26%
+2,022,495
New +$66.3M
1
2 3 4 5

Similar funds

MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
MCM
Mill Capital Management Concord, North Carolina $1.31B AUM 17.4% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Levin Capital Strategies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Levin Capital Strategies, which disclosed 318 positions worth $5.56B. Its ten largest holdings account for 35% of the portfolio.

Its largest position is Pfizer: 10,274,072 shares worth $273M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Healthcare and Technology.

  • Levin Capital Strategies's largest Q2 2013 buy was Pfizer: 10,274,072 shares worth $273M.
  • Levin Capital Strategies's ten largest holdings make up 35% of its $5.56B portfolio in Q2 2013.
  • Levin Capital Strategies disclosed 318 positions in Q2 2013, its first 13F filing on record.

Based on Levin Capital Strategies's 13F filing for Q2 2013, filed 13 Aug 2013.